News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
308,179 Results
Type
Article (18327)
Company Profile (37)
Press Release (289814)
Multimedia
Podcasts (20)
Webinars (9)
Section
Business (81586)
Career Advice (162)
Deals (12688)
Drug Delivery (38)
Drug Development (37413)
Employer Resources (20)
FDA (5365)
Job Trends (4197)
News (136020)
Policy (10487)
Tag
2027 BioMidwest Elite (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (676)
Accelerated approval (25)
Adcomms (3)
Allergies (98)
Alliances (22203)
ALS (103)
Alzheimer's disease (619)
Antibody-drug conjugate (ADC) (292)
Approvals (5749)
Artificial intelligence (337)
Autoimmune disease (238)
Automation (28)
Bankruptcy (82)
Best Places to Work (3649)
Biosimilars (95)
Biotechnology (28)
Bladder cancer (146)
Brain cancer (30)
Breast cancer (463)
Cancer (3572)
Cardiovascular disease (259)
Career advice (142)
Career pathing (2)
CAR-T (228)
CDC (12)
Celiac Disease (1)
Cell therapy (522)
Cervical cancer (19)
Clinical research (33835)
Collaboration (1124)
Compensation (560)
Complete response letters (24)
COVID-19 (2027)
CRISPR (64)
C-suite (625)
Cystic fibrosis (79)
Data (4973)
Decentralized trials (1)
Denatured (1)
Depression (70)
Dermatology (60)
Diabetes (244)
Diagnostics (2382)
Digital health (20)
Diversity (4)
Diversity, equity & inclusion (6)
Drug discovery (150)
Drug pricing (43)
Drug shortages (7)
Duchenne muscular dystrophy (112)
Earnings (26589)
Editorial (10)
Employer branding (2)
Employer resources (20)
Events (55542)
Executive appointments (663)
FDA (7385)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (15)
Funding (997)
Gene editing (129)
Generative AI (21)
Gene therapy (319)
GLP-1 (352)
Government (1424)
Grass and pollen (6)
Guidances (244)
Healthcare (4989)
HIV (59)
Huntington's disease (29)
IgA nephropathy (75)
Immunology and inflammation (145)
Immuno-oncology (55)
Indications (109)
Infectious disease (2229)
Inflammatory bowel disease (117)
Inflation Reduction Act (5)
Influenza (90)
Intellectual property (119)
Interviews (30)
IPO (4993)
IRA (8)
Job creations (884)
Job search strategy (125)
JPM (17)
Kidney cancer (10)
Labor market (9)
Layoffs (106)
Leadership (3)
Legal (2386)
Liver cancer (56)
Longevity (9)
Lung cancer (476)
Lymphoma (383)
Machine learning (24)
Management (5)
Manufacturing (395)
MASH (126)
Medical device (3013)
Medtech (3058)
Mergers & acquisitions (8354)
Metabolic disorders (625)
mRNA (94)
Multiple sclerosis (121)
NASH (10)
Neurodegenerative disease (203)
Neuropsychiatric disorders (43)
Neuroscience (1352)
NextGen: Class of 2026 (1575)
Non-profit (635)
Now hiring (2)
Obesity (236)
Opinion (125)
Ovarian cancer (142)
Pain (118)
Pancreatic cancer (187)
Parkinson's disease (188)
Partnered (9)
Patents (237)
Patient recruitment (399)
Peanut (36)
People (34814)
Pharmaceutical (10)
Pharmacy benefit managers (9)
Phase 1 (11417)
Phase 2 (15537)
Phase 3 (10389)
Pipeline (5219)
Policy (52)
Postmarket research (1008)
Preclinical (4128)
Press Release (16)
Prostate cancer (192)
Psychedelics (11)
Radiopharmaceuticals (105)
Rare diseases (529)
Real estate (1738)
Recruiting (10)
Regulatory (9205)
Reports (9)
Research institute (661)
Resumes & cover letters (20)
Rett syndrome (30)
RNA editing (13)
RSV (54)
Schizophrenia (71)
Series A (154)
Series B (229)
Service/supplier (2)
Sickle cell disease (59)
Special edition (5)
Spinal muscular atrophy (67)
Sponsored (13)
Startups (1921)
Stomach cancer (5)
Supply chain (48)
Tariffs (20)
The Weekly (19)
Vaccines (552)
Venture capital (47)
Weight loss (129)
Women's health (55)
Date
Last 7 days (371)
Last 30 days (1764)
Last 365 days (15724)
2026 (6787)
2025 (16071)
2024 (14141)
2023 (13780)
2022 (19280)
2021 (22406)
2020 (19414)
2019 (10454)
2018 (7945)
2017 (14273)
2016 (16847)
2015 (21247)
2014 (15945)
2013 (13441)
2012 (13882)
2011 (13558)
2010 (11844)
Location
Africa (292)
Alabama (36)
Arizona (96)
Arkansas (9)
Asia (19041)
Australia (2840)
California (7340)
Canada (1743)
China (697)
Colorado (303)
Connecticut (355)
Delaware (282)
Europe (46002)
Florida (834)
Georgia (228)
Hawaii (3)
Idaho (17)
Illinois (624)
India (40)
Indiana (186)
Iowa (11)
Japan (347)
Kansas (56)
Kentucky (18)
Louisiana (17)
Maine (11)
Maryland (698)
Massachusetts (5330)
Michigan (123)
Minnesota (279)
Mississippi (1)
Missouri (67)
Montana (10)
Nebraska (4)
Nevada (100)
New Hampshire (25)
New Jersey (1884)
New Mexico (7)
New York (1732)
North Carolina (736)
North Dakota (5)
Northern California (3849)
Ohio (167)
Oklahoma (6)
Oregon (16)
Pennsylvania (1123)
Puerto Rico (8)
Rhode Island (19)
South America (533)
South Carolina (11)
Southern California (2736)
Tennessee (67)
Texas (1187)
United States (24108)
Utah (109)
Virginia (163)
Washington D.C. (27)
Washington State (586)
West Virginia (1)
Wisconsin (107)
Wyoming (1)
308,179 Results for "cergentis b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
December 15, 2025
·
3 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference
April 9, 2026
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update
April 23, 2026
·
19 min read
Immunology and inflammation
Sanofi Keeps Immuno Deals Coming With Kali Bet Worth Potential $1B+
Kali Therapeutics’ T cell engager, for which Sanofi is initially paying $180 million, could potentially be developed for a range of B cell–driven autoimmune disorders.
March 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
April 15, 2026
·
3 min read
Press Releases
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
May 7, 2026
·
6 min read
Funding
Recordati fields $12.4B go-private offer
Going private could give Recordati strategic flexibility and a stable source of capital, according to CVC Capital Partners and Groupe Bruxelles Lambert, which are offering to take the Italian pharma private for a 13% premium.
May 22, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical testing, is focused on B cell–driven autoimmune diseases.
February 9, 2026
·
2 min read
·
Dan Samorodnitsky
1 of 30,818
Next
